LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial...
PENTICTON, BC / ACCESSWIRE / March 23, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), reports that, pursuant to...
Finalized pivotal Phase 3 trial design following formal meetings with FDAReceived FDA Fast Track designation for gedatolisib in HR+/HER2- metastatic...
GOTHENBURG, SE / ACCESSWIRE / March 23, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Today XVIVO announces an important milestone as the...
Healthcare technology leader to unveil ModMed AMP, a solution that includes website design & management, digital marketing, reputation management and...
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company")...
An index-tracking ETF that provides exposure to companies that comprise the digital health industry WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P....
Blood glucose meters allow regular at-home blood sugar checks to complement telemedicine visits, diabetes medications, lab tests, and ongoing diabetes...
CHICAGO , March 23, 2022 /PRNewswire/ -- SullivanCotter, the nation's leading independent consulting firm in the assessment and development of total...
To Deliver Low Dose Intravenous Ketamine for Mood and Anxiety Disorders, a Recommended Treatment by Canadian Guidelines, Upon Clinic LicensingOAKVILLE,...
CLEARWATER, FL / ACCESSWIRE / March 23, 2022 / Mercury Medical responds to the plea from the Ukrainian Medical Association...
CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with...
ENGLEWOOD, CO / ACCESSWIRE / March 23, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
GAITHERSBURG, MD / ACCESSWIRE / March 23, 2022 / BullFrog AI Holdings, Inc., a biopharmaceutical company focused on applying its...
Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002OAKVILLE,...
Two 25 μg doses of mRNA-1273 in participants 6 months to under 6 years met primary endpoint with robust neutralizing...
RALEIGH, NC / ACCESSWIRE / March 23, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
SRP-3D (DA) has demonstrated a compelling safety profile over currently available pain medicationsPotential to address the significant unmet need for...
PacBio Logo in New London Office PacBio opens new office in London.Company Announces New European Headquarters to Serve Growing Customer...
Origin Therapeutics’ portfolio company, Microdose Psychedelic Insights, will host the Microdose Psychedelic Capital event virtually on March 24Vancouver, British Columbia,...